$CVSI
CV Sciences, Inc. Stock $cvsi

$cvsi Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-K Financial Statement

#000151096419000007 Filed on March 12, 2019

Income Statement

Concept	2018 Q4	2018	2017 Q4
Revenue	$14.22M	$48.24M
YoY Change		133.3%
Cost Of Revenue	$4.913M	$14.37M
YoY Change		132.08%
Gross Profit	$9.311M	$33.88M
YoY Change		133.82%
Gross Profit Margin	65.46%	70.22%
Selling, General & Admin	$5.794M	$21.75M
YoY Change		34.29%
% of Gross Profit	62.24%	64.19%
Research & Development	$759.7K	$1.885M
YoY Change		160.36%
% of Gross Profit	8.16%	5.56%
Depreciation & Amortization	$143.3K	$519.0K	$40.00K
YoY Change	258.33%	183.61%	-84.62%
% of Gross Profit	1.54%	1.53%
Operating Expenses	$6.554M	$23.63M
YoY Change		22.13%
Operating Profit	$2.756M	$10.25M
YoY Change		-310.84%
Interest Expense	-$2.610K	$153.0K
YoY Change		-69.82%
% of Operating Profit	-0.09%	1.49%
Other Income/Expense, Net	$0.00	$0.00
YoY Change		-100.0%
Pretax Income	$2.754M	$10.09M
YoY Change		-287.66%
Income Tax	-$147.0K	$93.00K
% Of Pretax Income	-5.34%	0.92%
Net Earnings	$2.901M	$10.00M
YoY Change		-304.23%
Net Earnings / Revenue	20.39%	20.73%
Basic Earnings Per Share		$0.11
Diluted Earnings Per Share	$23.01K	$0.09
COMMON SHARES
Basic Shares Outstanding		91.92M shares
Diluted Shares Outstanding		114.5M shares

Balance Sheet

Concept	2018 Q4	2018	2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.68M	$12.68M	$2.010M
YoY Change	531.04%	530.11%	157.69%
Cash & Equivalents	$12.68M	$12.68M	$2.792M
Short-Term Investments
Other Short-Term Assets	$585.0K	$2.310M	$400.0K
YoY Change	46.25%	45.12%	-51.81%
Inventory	$7.132M	$7.132M	$2.823M
Prepaid Expenses	$2.059M		$813.0K
Receivables	$3.340M	$3.340M	$1.507M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$25.47M	$25.47M	$7.935M
YoY Change	220.93%	220.93%	64.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.844M	$2.844M	$2.084M
YoY Change	36.47%	36.51%	768.33%
Goodwill	$2.788M		$2.788M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$585.0K	$2.003M	$6.070M
YoY Change	-90.36%	-66.99%	-6.33%
Total Long-Term Assets	$11.44M	$11.44M	$14.78M
YoY Change	-22.6%	-22.6%	7.3%
TOTAL ASSETS
Total Short-Term Assets	$25.47M	$25.47M	$7.935M
Total Long-Term Assets	$11.44M	$11.44M	$14.78M
Total Assets	$36.90M	$36.90M	$22.71M
YoY Change	62.49%	62.49%	22.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.245M	$1.245M	$678.0K
YoY Change	83.63%	83.56%	30.38%
Accrued Expenses	$2.673M	$2.673M	$1.932M
YoY Change	38.35%	38.36%	408.42%
Deferred Revenue
YoY Change
Short-Term Debt	$474.0K	$474.0K	$730.0K
YoY Change	-35.07%	-34.74%	-63.86%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.392M	$4.392M	$3.336M
YoY Change	31.65%	31.64%	5.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$850.0K
YoY Change	-100.0%	-100.0%	25.0%
Other Long-Term Liabilities	$0.00	$1.329M	$1.070M
YoY Change	-100.0%	24.5%
Total Long-Term Liabilities	$0.00	$1.329M	$1.920M
YoY Change	-100.0%	-30.69%	182.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.392M	$4.392M	$3.336M
Total Long-Term Liabilities	$0.00	$1.329M	$1.920M
Total Liabilities	$6.786M	$6.786M	$6.329M
YoY Change	7.22%	7.22%	17.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.03M		-$35.03M
YoY Change	-28.55%
Common Stock	$9.000K		$9.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$30.12M	$30.12M	$16.38M
YoY Change
Total Liabilities & Shareholders Equity	$36.90M	$36.90M	$22.71M
YoY Change	62.49%	62.49%	22.16%

Cashflow Statement

Concept	2018 Q4	2018	2017 Q4
OPERATING ACTIVITIES
Net Income	$2.901M	$10.00M
YoY Change		-304.23%
Depreciation, Depletion And Amortization	$143.3K	$519.0K	$40.00K
YoY Change	258.33%	183.61%	-84.62%
Cash From Operating Activities	$2.633M	$12.56M	$2.970M
YoY Change	-11.34%	247.41%	-579.03%
INVESTING ACTIVITIES
Capital Expenditures	-$819.7K	$893.0K	-$1.990M
YoY Change	-58.81%	96.7%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$819.7K	-$1.244M	-$1.990M
YoY Change	-58.81%	-37.8%	-328.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	111.1K	-$1.172M	-500.0K
YoY Change	-122.21%	-1084.87%	1150.0%
NET CHANGE
Cash From Operating Activities	2.633M	$12.56M	2.970M
Cash From Investing Activities	-819.7K	-$1.244M	-1.990M
Cash From Financing Activities	111.1K	-$1.172M	-500.0K
Net Change In Cash	1.925M	$10.14M	480.0K
YoY Change	300.95%	484.95%	128.57%
FREE CASH FLOW
Cash From Operating Activities	$2.633M	$12.56M	$2.970M
Capital Expenditures	-$819.7K	$893.0K	-$1.990M
Free Cash Flow	$3.453M	$11.67M	$4.960M
YoY Change	-30.39%	269.06%	-900.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22710000	USD
CY2018	cvsi	Accounts Receivable Thresholdfor Determining Delinquent Account AccountsReceivableThresholdforDeterminingDelinquentAccount	P30D
CY2017	cvsi	Accrual For Required Stock Redemption AccrualForRequiredStockRedemption	75000	USD
CY2018	cvsi	Accrual For Required Stock Redemption AccrualForRequiredStockRedemption	0	USD
CY2017	cvsi	Amortization Of Derivative Liability Discount AmortizationOfDerivativeLiabilityDiscount	29000	USD
CY2018	cvsi	Amortization Of Derivative Liability Discount AmortizationOfDerivativeLiabilityDiscount	0	USD
CY2016Q4	cvsi	Cash And Restricted Cash CashAndRestrictedCash	1058000	USD
CY2017Q4	cvsi	Cash And Restricted Cash CashAndRestrictedCash	2792000	USD
CY2018Q4	cvsi	Cash And Restricted Cash CashAndRestrictedCash	12935000	USD
CY2018	cvsi	Cash Unrestrictedduring Period CashUnrestrictedduringPeriod	450000	USD
CY2017	cvsi	Conversion Of Convertible Promissory Notes And Accrued Interest To Common Stock ConversionOfConvertiblePromissoryNotesAndAccruedInterestToCommonStock	1805000	USD
CY2018	cvsi	Conversion Of Convertible Promissory Notes And Accrued Interest To Common Stock ConversionOfConvertiblePromissoryNotesAndAccruedInterestToCommonStock	0	USD
CY2017Q4	cvsi	Debt Instrument Numberof Periodic Payments DebtInstrumentNumberofPeriodicPayments	9	payment
CY2018Q4	cvsi	Deferred Tax Assets Disqualified Incentive Stock Options DeferredTaxAssetsDisqualifiedIncentiveStockOptions	3538000	USD
CY2017	cvsi	Effect Of Change In Future Tax Rate On Deferred Tax Balances EffectOfChangeInFutureTaxRateOnDeferredTaxBalances	2226000	USD
CY2018	cvsi	Effect Of Change In Future Tax Rate On Deferred Tax Balances EffectOfChangeInFutureTaxRateOnDeferredTaxBalances	0	USD
CY2017	cvsi	Effective Income Tax Rate Reconciliation Changein Derivative Liability Percent EffectiveIncomeTaxRateReconciliationChangeinDerivativeLiabilityPercent	0.016
CY2018	cvsi	Effective Income Tax Rate Reconciliation Changein Derivative Liability Percent EffectiveIncomeTaxRateReconciliationChangeinDerivativeLiabilityPercent	0.000
CY2017	cvsi	Effective Income Tax Rate Reconciliation Nondeductible Intereston Convertible Notes Percent EffectiveIncomeTaxRateReconciliationNondeductibleInterestonConvertibleNotesPercent	-0.025
CY2018	cvsi	Effective Income Tax Rate Reconciliation Nondeductible Intereston Convertible Notes Percent EffectiveIncomeTaxRateReconciliationNondeductibleInterestonConvertibleNotesPercent	0.001
CY2017	cvsi	Effective Income Tax Rate Reconciliation Royalty Buyout Percent EffectiveIncomeTaxRateReconciliationRoyaltyBuyoutPercent	-0.154
CY2018	cvsi	Effective Income Tax Rate Reconciliation Royalty Buyout Percent EffectiveIncomeTaxRateReconciliationRoyaltyBuyoutPercent	0.000
CY2017	cvsi	Effectof Changein Future Tax Rateon Deferred Tax Balances Percent EffectofChangeinFutureTaxRateonDeferredTaxBalancesPercent	-0.414
CY2018	cvsi	Effectof Changein Future Tax Rateon Deferred Tax Balances Percent EffectofChangeinFutureTaxRateonDeferredTaxBalancesPercent	0.000
CY2017	cvsi	Equity Consideration For Royalty Buyout EquityConsiderationForRoyaltyBuyout	2000	USD
CY2018	cvsi	Equity Consideration For Royalty Buyout EquityConsiderationForRoyaltyBuyout	0	USD
CY2017	cvsi	Fair Value Of Warrants Issued In Connection With Unsecured Promissory Note FairValueOfWarrantsIssuedInConnectionWithUnsecuredPromissoryNote	137000	USD
CY2017	cvsi	Income Tax Reconciliation Change In Derivative Liability IncomeTaxReconciliationChangeInDerivativeLiability	-85000	USD
CY2018	cvsi	Income Tax Reconciliation Change In Derivative Liability IncomeTaxReconciliationChangeInDerivativeLiability	0	USD
CY2017	cvsi	Income Tax Reconciliation Nondeductible Expense Interest IncomeTaxReconciliationNondeductibleExpenseInterest	135000	USD
CY2018	cvsi	Income Tax Reconciliation Nondeductible Expense Interest IncomeTaxReconciliationNondeductibleExpenseInterest	11000	USD
CY2017	cvsi	Income Tax Reconciliation Nondeductible Expense Royalty Buyout IncomeTaxReconciliationNondeductibleExpenseRoyaltyBuyout	827000	USD
CY2018	cvsi	Income Tax Reconciliation Nondeductible Expense Royalty Buyout IncomeTaxReconciliationNondeductibleExpenseRoyaltyBuyout	0	USD
CY2017	cvsi	Incremental Common Shares Attributableto Dilutive Effectof Performance Stock Options IncrementalCommonSharesAttributabletoDilutiveEffectofPerformanceStockOptions	0	shares
CY2018	cvsi	Incremental Common Shares Attributableto Dilutive Effectof Performance Stock Options IncrementalCommonSharesAttributabletoDilutiveEffectofPerformanceStockOptions	6215000	shares
CY2017	cvsi	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
CY2018	cvsi	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	2950000	shares
CY2017	cvsi	Incremental Common Shares Attributableto Dilutive Effectof Stock Options IncrementalCommonSharesAttributabletoDilutiveEffectofStockOptions	0	shares
CY2018	cvsi	Incremental Common Shares Attributableto Dilutive Effectof Stock Options IncrementalCommonSharesAttributabletoDilutiveEffectofStockOptions	13389000	shares
CY2018	cvsi	Maximum Lengthof Time Credit Card Processor Cash Reserve Holding Period MaximumLengthofTimeCreditCardProcessorCashReserveHoldingPeriod	P270D
CY2017	cvsi	Net Operating Loss Carryforward Tax Benefit NetOperatingLossCarryforwardTaxBenefit	0	USD
CY2018	cvsi	Net Operating Loss Carryforward Tax Benefit NetOperatingLossCarryforwardTaxBenefit	3224000	USD
CY2017	cvsi	Numberof Litigation Matterswith Companyas Plaintiff NumberofLitigationMatterswithCompanyasPlaintiff	2	complaint
CY2017	cvsi	Payments To Tenantleasehold Incentive PaymentsToTenantleaseholdIncentive	1546000	USD
CY2018	cvsi	Payments To Tenantleasehold Incentive PaymentsToTenantleaseholdIncentive	351000	USD
CY2017	cvsi	Purchase Of Insurance Through Issuance Of Note Payable PurchaseOfInsuranceThroughIssuanceOfNotePayable	149000	USD
CY2018	cvsi	Purchase Of Insurance Through Issuance Of Note Payable PurchaseOfInsuranceThroughIssuanceOfNotePayable	533000	USD
CY2017	cvsi	Repayments Of Convertible Debt In Cash RepaymentsOfConvertibleDebtInCash	472000	USD
CY2018	cvsi	Repayments Of Convertible Debt In Cash RepaymentsOfConvertibleDebtInCash	660000	USD
CY2018	cvsi	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Peers Includedin Calculationof Expected Volatility SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility	5	company
CY2017Q1	cvsi	Sharebased Compensation Arrangementby Sharebased Payment Award Options Outstanding Modified Number SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsOutstandingModifiedNumber	6090000	shares
CY2017Q1	cvsi	Sharebased Compensation Arrangementby Sharebased Payment Award Plan Modification Incremental Unrecognized Compensation Cost SharebasedCompensationArrangementbySharebasedPaymentAwardPlanModificationIncrementalUnrecognizedCompensationCost	418000	USD
CY2017Q1	cvsi	Sharebasedcompensation Arrangementby Sharebased Payment Award Options Modified Weighted Average Exercise Price SharebasedcompensationArrangementbySharebasedPaymentAwardOptionsModifiedWeightedAverageExercisePrice	0.38
CY2017	cvsi	Shares Issued In Exchange For Purchase Of Inventory SharesIssuedInExchangeForPurchaseOfInventory	202000	USD
CY2018	cvsi	Shares Issued In Exchange For Purchase Of Inventory SharesIssuedInExchangeForPurchaseOfInventory	0	USD
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001510964
CY2017	cvsi	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpense	482000	USD
CY2017	cvsi	Value Of Embedded Derivative At Inception ValueOfEmbeddedDerivativeAtInception	29000	USD
CY2018	cvsi	Value Of Embedded Derivative At Inception ValueOfEmbeddedDerivativeAtInception	0	USD
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	95669588	shares
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2018Q2	dei	Entity Public Float EntityPublicFloat	132000000	USD
CY2018	dei	Entity Registrant Name EntityRegistrantName	CV Sciences, Inc.
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	true
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018	dei	Trading Symbol TradingSymbol	CVSI
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	678000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1245000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1507000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3340000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1932000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2673000	USD
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1037000	USD
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1222000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	399000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	883000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51400000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55134000	USD
CY2017	us-gaap	Adjustment For Amortization AdjustmentForAmortization	35000	USD
CY2018	us-gaap	Adjustment For Amortization AdjustmentForAmortization	35000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3419000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2925000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	380000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	907000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	200000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	200000	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	221000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	51000	USD
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43923000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11600000	shares
CY2017Q4	us-gaap	Assets Assets	22710000	USD
CY2018Q4	us-gaap	Assets Assets	36902000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	7935000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	25466000	USD
CY2017Q4	us-gaap	Cash Cash	2013000	USD
CY2018Q4	us-gaap	Cash Cash	12684000	USD
CY2017Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2017	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	1734000	USD
CY2018	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	10143000	USD
CY2018Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	12721000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	190000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	190000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	90513000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	94940000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90513000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94940000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2017	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0
CY2018	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0
CY2017Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1068000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1329000	USD
CY2017Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	610000	USD
CY2018Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	6190000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	14366000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3327000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-482000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-10000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1405000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1751000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1075000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1065000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1113000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1002000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6804000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7746000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	997000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3593000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1608000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	127000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	129000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	100000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	100000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	299000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	372000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	575000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4535000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6474000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7060000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1074000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1064000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	331000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	687000	USD
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	83000	USD
CY2017	us-gaap	Depreciation Depreciation	147000	USD
CY2018	us-gaap	Depreciation Depreciation	484000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	183000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	519000	USD
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.090
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.009
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.464
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.058
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.017
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.012
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.127
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.266
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.007
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.006
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7363000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y1M6D
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	137000	USD
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	71000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	106000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	35000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	36000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3907000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3907000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21746000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3836000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3801000	USD
CY2017	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	249000	USD
CY2018	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-12000	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2017Q4	us-gaap	Goodwill Goodwill	2788000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	2788000	USD
CY2017	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2018	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2018	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5379000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6648000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10094000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-482000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4747000	USD
CY2017	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16193000	USD
CY2017	us-gaap	Gross Profit GrossProfit	14489000	USD
CY2018	us-gaap	Gross Profit GrossProfit	33878000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2494000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	586000	USD
CY2018	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	295000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	6329000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1829000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2120000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	90000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	117000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	685000	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2680000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-37000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-61000	USD
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	44000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	70000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1780000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1308000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1241000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1882000	USD
CY2017	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	981000	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	195000	USD
CY2017	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	482000	USD
CY2018	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	10000	USD
CY2017	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	189000	USD
CY2018	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1043000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	60000	USD
CY2017	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	25000	USD
CY2018	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	0	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	400000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	832000	USD
CY2017	us-gaap	Interest Expense InterestExpense	507000	USD
CY2018	us-gaap	Interest Expense InterestExpense	153000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	183000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	153000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1842000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3803000	USD
CY2017Q4	us-gaap	Inventory Gross InventoryGross	8490000	USD
CY2018Q4	us-gaap	Inventory Gross InventoryGross	8550000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	2823000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	7132000	USD
CY2017Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	5667000	USD
CY2018Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1418000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	6786000	USD
CY2018	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2018	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Notes Payable NotesPayable	474000	USD
CY2017Q4	us-gaap	Notes Payable Current NotesPayableCurrent	726000	USD
CY2018Q4	us-gaap	Notes Payable Current NotesPayableCurrent	474000	USD
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36902000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3336000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4392000	USD
CY2017Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	USD
CY2018Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	USD
CY2017Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	850000	USD
CY2018Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	119000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1172000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1244000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3615000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12559000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-4897000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	10001000	USD
CY2017Q4	us-gaap	Notes Payable NotesPayable	1576000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	19349000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	23631000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-4860000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	10247000	USD
CY2017	us-gaap	Operating Lease Expense OperatingLeaseExpense	480000	USD
CY2018	us-gaap	Operating Lease Expense OperatingLeaseExpense	720000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6780000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	925000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	957000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	929000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	923000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	961000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2085000	USD
CY2018	us-gaap	Operating Loss Carryforwards Expiration Date OperatingLossCarryforwardsExpirationDate	2033-12-31
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	895000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1451000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	400000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	585000	USD
CY2017	us-gaap	Other Expenses OtherExpenses	12000	USD
CY2018	us-gaap	Other Expenses OtherExpenses	0	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-519000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-153000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	454000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	893000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	779000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	251000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35028000	USD
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1805000	USD
CY2018	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	295000	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	813000	USD
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2059000	USD
CY2017	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	750000	USD
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	514000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2483000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3727000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2084000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2844000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	483000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	49000	USD
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	159000	USD
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	176000	USD
CY2017	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	USD
CY2018	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	850000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	724000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1885000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25027000	USD
CY2017	us-gaap	Revenues Revenues	20679000	USD
CY2018	us-gaap	Revenues Revenues	48244000	USD
CY2017	us-gaap	Royalty Expense RoyaltyExpense	2432000	USD
CY2018	us-gaap	Royalty Expense RoyaltyExpense	0	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16193000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21746000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	3419000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	2925000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.955
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.901
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.026
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5903000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.15
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.72
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	414000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	4000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y1M13D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y5M9D
CY2017	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	500000	shares
CY2017	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2017	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2432000	USD
CY2017	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	202000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	16381000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	30116000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	514000	USD
CY2017	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	75000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	13208000	USD
CY2017Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	116000	USD
CY2018Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	474000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-2494000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	586000	USD
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80432000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114470000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80432000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91916000	shares
CY2018	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Credit Risk</font><font style="font-family:inherit;font-size:10pt;"> – As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Federal Deposit Insurance Corporation (“FDIC”) provided insurance coverage of up to </font><font style="font-family:inherit;font-size:10pt;">$250</font><font style="font-family:inherit;font-size:10pt;"> per depositor per bank. The Company has not experienced any losses in such accounts and does not believe that the Company is exposed to significant risks from excess deposits. The Company’s cash balance in excess of FDIC limits totaled </font><font style="font-family:inherit;font-size:10pt;">$12,721</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was no concentration of accounts receivable, revenue and inventory purchases as of and for the years ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font><font style="font-family:inherit;font-size:10pt;"> – The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates. Significant estimates include the valuation of intangible assets, the amortization lives of intangible assets, valuation of contingent consideration, inputs for valuing derivative financial instruments, inputs for valuing equity awards and warrants, inputs for valuing notes payable beneficial conversion features, valuation of inventory, classification of current and non-current inventory amounts, assumptions related to revenue recognition and the allowance for doubtful accounts.</font></div></div>

Files In Submission

Name	View Source	Status
0001510964-19-000007-index-headers.html	Edgar Link	pending
0001510964-19-000007-index.html	Edgar Link	pending
0001510964-19-000007.txt	Edgar Link	pending
0001510964-19-000007-xbrl.zip	Edgar Link	pending
a302certificationcao.htm	Edgar Link	pending
a302certificationceo.htm	Edgar Link	pending
a906certificationcao.htm	Edgar Link	pending
a906certificationceo.htm	Edgar Link	pending
consent.htm	Edgar Link	pending
cvsi-20181231.xml	Edgar Link	completed
cvsi-20181231.xsd	Edgar Link	pending
cvsi-20181231x10xk.htm	Edgar Link	pending
cvsi-20181231_cal.xml	Edgar Link	unprocessable
cvsi-20181231_def.xml	Edgar Link	unprocessable
cvsi-20181231_lab.xml	Edgar Link	unprocessable
cvsi-20181231_pre.xml	Edgar Link	unprocessable
employmentagreementgrasser.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
subsidiaries.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVSI
CV Sciences, Inc. Stock $cvsi

2018 Q4 Form 10-K Financial Statement

#000151096419000007 Filed on March 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVSI CV Sciences, Inc. Stock $cvsi

2018 Q4 Form 10-K Financial Statement

#000151096419000007 Filed on March 12, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVSI
CV Sciences, Inc. Stock $cvsi